EarningsSQURPHARMA
SQURPHARMA Earnings Update
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 31 January 2021. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q2 Un-audited): Consolidated EPS was Tk. 4.18 for October-December 2020 as against Tk. 3.70 for October-December 2019; Consolidated EPS was Tk. 8.76 for July-December 2020 as against Tk. 7.77 for July-December 2019. Consolidated NOCFPS was Tk. 7.28 for July-December 2020 as against Tk. 5.60 for July-December 2019. Consolidated NAV per share was Tk. 92.47 as on December 31, 2020 and Tk. 87.28 as on June 30, 2020.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace4e5a6b000040054724
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.